Field Notes #5: ‘Psychedelics Week’ in Washington D.C.

What Lynn Watkins Actually Told the FDA about Chronic Pain and...

Beyond the Foxhole: How Psychedelic Policy’s Coalition Is Growing Past Veterans

‘Move Fast, with Precision’: Notes from ARPA-H’s Ibogaine Workshop

Pα+ Psychedelic Bulletin #231: Compass Shares 52 Week Follow-Up, Training Grant...

No Questions Asked: FDA’s Psychedelics Public Hearing

Definium Notches Second Positive Phase 3 in Generalised Anxiety Disorder

THE GATEWAY: Live From DC After the FDA Psychedelics Hearing

Approvals to Access: A Crude Schematic

Davis, Farchione and Colleagues Present FDA’s Psychedelic Drug Framework in NEJM

123...325Page 1 of 325